Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Filtros aplicados
Base de dados
Intervalo de ano de publicação
1.
J. physiol. biochem ; 72(4): 689-697, dic. 2016. tab, graf
Artigo em Inglês | IBECS | ID: ibc-168376

RESUMO

The balance of ATP production and consumption is reflected in adenosine monophosphate (AMP) and nicotinamide adenine dinucleotide (NAD) content and has been associated with phenotypic plasticity in striated muscle. Some studies have suggested that AMPK-dependent plasticity may be an indirect consequence of increased NAD synthesis and SIRT1 activity. The primary goal of this study was to assess the interaction of AMP- and NAD-dependent signaling in adaptation of C2C12 myotubes. Changes in myotube developmental and metabolic gene expression were compared following incubation with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and nicotinamide mononucleotide (NMN) to activate AMPK- and NAD-related signaling. AICAR showed no effect on NAD pool or nampt expression but significantly reduced histone H3 acetylation and GLUT1, cytochrome C oxidase subunit 2 (COX2), and MYH3 expression. In contrast, NMN supplementation for 24 h increased NAD pool by 45 % but did not reduce histone H3 acetylation nor promote mitochondrial gene expression. The combination of AMP and NAD signaling did not induce further metabolic adaptation, but NMN ameliorated AICAR-induced myotube reduction. We interpret these results as indication that AMP and NAD contribute to C2C12 differentiation and metabolic adaptation independently (AU)


No disponible


Assuntos
Animais , Camundongos , Adaptação Fisiológica , Transdução de Sinais , NAD/metabolismo , Mioblastos/metabolismo , Monofosfato de Adenosina/metabolismo , Acetilação , Linhagem Celular , Diferenciação Celular , Aminoimidazol Carboxamida , Complexo IV da Cadeia de Transporte de Elétrons , Cadeias Pesadas de Miosina , Transportador de Glucose Tipo 1 , Mononucleotídeo de Nicotinamida/farmacologia , Ribonucleotídeos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA